|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling and marketing expenses | |||||
| General, administrative and other expenses | |||||
| Loss on disposal of business | |||||
| Equity income in earnings of unconsolidated affiliates | |||||
| Operating income | |||||
| Other expense, net: | |||||
| Interest expense, net | |||||
| Loss on extinguishment of debt | |||||
| Other expense (income), net | |||||
| Total other expense, net | |||||
| Income before income taxes | |||||
| Income tax provision | |||||
| Income from continuing operations | |||||
| Loss from discontinued operations, net of tax | |||||
| Net income before non-controlling interest | |||||
| Less: Net income attributable to non-controlling interest | |||||
| Net income attributable to Somnigroup International Inc. | |||||
| Earnings per common share: | |||||
| Loss per share for discontinued operations (in dollars per share) | |||||
| Basic (in dollars per share) | |||||
| Earnings per share for continuing operations (in dollars per share) | |||||
| Loss per share for discontinued operations (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...